162 related articles for article (PubMed ID: 38731851)
1. The Immune Response of
Gajate-Arenas M; Fricke-Galindo I; García-Pérez O; Domínguez-de-Barros A; Pérez-Rubio G; Dorta-Guerra R; Buendía-Roldán I; Chávez-Galán L; Lorenzo-Morales J; Falfán-Valencia R; Córdoba-Lanús E
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731851
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of antiviral and immune-related genes in individuals with COVID-19 asymptomatic or with mild symptoms.
Gajate-Arenas M; García-Pérez O; Chao-Pellicer J; Domínguez-De-Barros A; Dorta-Guerra R; Lorenzo-Morales J; Córdoba-Lanus E
Front Cell Infect Microbiol; 2023; 13():1173213. PubMed ID: 37389217
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene.
Zhu Y; Zhang Z; Song J; Qian W; Gu X; Yang C; Shen N; Xue F; Tang Y
Front Immunol; 2021; 12():767726. PubMed ID: 35003084
[TBL] [Abstract][Full Text] [Related]
4. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
Magusali N; Graham AC; Piers TM; Panichnantakul P; Yaman U; Shoai M; Reynolds RH; Botia JA; Brookes KJ; Guetta-Baranes T; Bellou E; Bayram S; Sokolova D; Ryten M; Sala Frigerio C; Escott-Price V; Morgan K; Pocock JM; Hardy J; Salih DA
Brain; 2021 Dec; 144(12):3727-3741. PubMed ID: 34619763
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide variants in the
Chávez-Vélez E; Álvarez-Nava F; Torres-Vinueza A; Balarezo-Díaz T; Pilataxi K; Acosta-López C; Peña IZ; Narváez K
Front Cell Infect Microbiol; 2024; 14():1322882. PubMed ID: 38694517
[TBL] [Abstract][Full Text] [Related]
6. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
Elife; 2021 Aug; 10():. PubMed ID: 34402426
[TBL] [Abstract][Full Text] [Related]
7. A prenylated dsRNA sensor protects against severe COVID-19.
Wickenhagen A; Sugrue E; Lytras S; Kuchi S; Noerenberg M; Turnbull ML; Loney C; Herder V; Allan J; Jarmson I; Cameron-Ruiz N; Varjak M; Pinto RM; Lee JY; Iselin L; Palmalux N; Stewart DG; Swingler S; Greenwood EJD; Crozier TWM; Gu Q; Davies EL; Clohisey S; Wang B; Trindade Maranhão Costa F; Freire Santana M; de Lima Ferreira LC; Murphy L; Fawkes A; Meynert A; Grimes G; ; Da Silva Filho JL; Marti M; Hughes J; Stanton RJ; Wang ECY; Ho A; Davis I; Jarrett RF; Castello A; Robertson DL; Semple MG; Openshaw PJM; Palmarini M; Lehner PJ; Baillie JK; Rihn SJ; Wilson SJ
Science; 2021 Oct; 374(6567):eabj3624. PubMed ID: 34581622
[TBL] [Abstract][Full Text] [Related]
8. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.
Zhou S; Butler-Laporte G; Nakanishi T; Morrison DR; Afilalo J; Afilalo M; Laurent L; Pietzner M; Kerrison N; Zhao K; Brunet-Ratnasingham E; Henry D; Kimchi N; Afrasiabi Z; Rezk N; Bouab M; Petitjean L; Guzman C; Xue X; Tselios C; Vulesevic B; Adeleye O; Abdullah T; Almamlouk N; Chen Y; Chassé M; Durand M; Paterson C; Normark J; Frithiof R; Lipcsey M; Hultström M; Greenwood CMT; Zeberg H; Langenberg C; Thysell E; Pollak M; Mooser V; Forgetta V; Kaufmann DE; Richards JB
Nat Med; 2021 Apr; 27(4):659-667. PubMed ID: 33633408
[TBL] [Abstract][Full Text] [Related]
9. Endomembrane targeting of human OAS1 p46 augments antiviral activity.
Soveg FW; Schwerk J; Gokhale NS; Cerosaletti K; Smith JR; Pairo-Castineira E; Kell AM; Forero A; Zaver SA; Esser-Nobis K; Roby JA; Hsiang TY; Ozarkar S; Clingan JM; McAnarney ET; Stone AE; Malhotra U; Speake C; Perez J; Balu C; Allenspach EJ; Hyde JL; Menachery VD; Sarkar SN; Woodward JJ; Stetson DB; Baillie JK; Buckner JH; Gale M; Savan R
Elife; 2021 Aug; 10():. PubMed ID: 34342578
[TBL] [Abstract][Full Text] [Related]
10. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.
Banday AR; Stanifer ML; Florez-Vargas O; Onabajo OO; Papenberg BW; Zahoor MA; Mirabello L; Ring TJ; Lee CH; Albert PS; Andreakos E; Arons E; Barsh G; Biesecker LG; Boyle DL; Brahier MS; Burnett-Hartman A; Carrington M; Chang E; Choe PG; Chisholm RL; Colli LM; Dalgard CL; Dude CM; Edberg J; Erdmann N; Feigelson HS; Fonseca BA; Firestein GS; Gehring AJ; Guo C; Ho M; Holland S; Hutchinson AA; Im H; Irby L; Ison MG; Joseph NT; Kim HB; Kreitman RJ; Korf BR; Lipkin SM; Mahgoub SM; Mohammed I; Paschoalini GL; Pacheco JA; Peluso MJ; Rader DJ; Redden DT; Ritchie MD; Rosenblum B; Ross ME; Anna HPS; Savage SA; Sharma S; Siouti E; Smith AK; Triantafyllia V; Vargas JM; Vargas JD; Verma A; Vij V; Wesemann DR; Yeager M; Yu X; Zhang Y; Boulant S; Chanock SJ; Feld JJ; Prokunina-Olsson L
Nat Genet; 2022 Aug; 54(8):1103-1116. PubMed ID: 35835913
[TBL] [Abstract][Full Text] [Related]
11. Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module.
Lee HK; Knabl L; Knabl L; Wieser M; Mur A; Zabernigg A; Schumacher J; Kapferer S; Kaiser N; Furth PA; Hennighausen L
Sci Rep; 2022 Feb; 12(1):2784. PubMed ID: 35181735
[TBL] [Abstract][Full Text] [Related]
12. Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor.
Danziger O; Patel RS; DeGrace EJ; Rosen MR; Rosenberg BR
PLoS Pathog; 2022 Apr; 18(4):e1010464. PubMed ID: 35421191
[TBL] [Abstract][Full Text] [Related]
13. Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication.
Lytras S; Wickenhagen A; Sugrue E; Stewart DG; Swingler S; Sims A; Jackson Ireland H; Davies EL; Ludlam EM; Li Z; Hughes J; Wilson SJ
PLoS Biol; 2023 Nov; 21(11):e3002398. PubMed ID: 38015855
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection.
Yousfi FZE; Haroun AE; Nebhani C; Belayachi J; Askander O; Fahime EE; Fares H; Ennibi K; Abouqal R; Razine R; Bouhouche A
Arch Virol; 2024 Apr; 169(5):109. PubMed ID: 38658463
[TBL] [Abstract][Full Text] [Related]
15. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.
He J; Feng D; de Vlas SJ; Wang H; Fontanet A; Zhang P; Plancoulaine S; Tang F; Zhan L; Yang H; Wang T; Richardus JH; Habbema JD; Cao W
BMC Infect Dis; 2006 Jul; 6():106. PubMed ID: 16824203
[TBL] [Abstract][Full Text] [Related]
16. OAS1 gene, Spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease?
Di Stadio A; Bernitsas E; Ralli M; Severini C; Brenner MJ; Angelini C
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):347-349. PubMed ID: 35113409
[No Abstract] [Full Text] [Related]
17. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19.
Huffman JE; Butler-Laporte G; Khan A; Pairo-Castineira E; Drivas TG; Peloso GM; Nakanishi T; ; Ganna A; Verma A; Baillie JK; Kiryluk K; Richards JB; Zeberg H
Nat Genet; 2022 Feb; 54(2):125-127. PubMed ID: 35027740
[TBL] [Abstract][Full Text] [Related]
18. Structure of the 5' untranslated region in SARS-CoV-2 genome and its specific recognition by innate immune system
Bignon E; Miclot T; Terenzi A; Barone G; Monari A
Chem Commun (Camb); 2022 Feb; 58(13):2176-2179. PubMed ID: 35060977
[TBL] [Abstract][Full Text] [Related]
19. Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort.
Skerenova M; Cibulka M; Dankova Z; Holubekova V; Kolkova Z; Lucansky V; Dvorska D; Kapinova A; Krivosova M; Petras M; Baranovicova E; Baranova I; Novakova E; Liptak P; Banovcin P; Bobcakova A; Rosolanka R; Janickova M; Stanclova A; Gaspar L; Caprnda M; Prosecky R; Labudova M; Gabbasov Z; Rodrigo L; Kruzliak P; Lasabova Z; Matakova T; Halasova E
Adv Med Sci; 2024 Mar; 69(1):198-207. PubMed ID: 38555007
[TBL] [Abstract][Full Text] [Related]
20. Correlation of OAS1 gene polymorphism at exon 7 splice accepter site with interferon-based therapy of HCV infection in Pakistan.
Imran M; Manzoor S; Khattak NM; Tariq M; Khalid M; Javed F; Bhatti S
Viral Immunol; 2014 Apr; 27(3):105-11. PubMed ID: 24673406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
